Neonatal Seizures. Advances in Mechanisms and Management.

Clinics in Perinatology

Volumn 41, Issue 1, 2014, Pages 177-190

  Glass, Hannah C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain injury; Developmental disability; Electroencephalography; Epilepsy; Infant, newborn; Magnetic resonance imaging; Neurocritical care; Seizures

Indexed keywords

BRAIN INJURY; DEVELOPMENTAL DISABILITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; NEUROCRITICAL CARE; SEIZURES;

ANTICONVULSANTS; BRAIN; CEREBRAL HEMORRHAGE; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; SEIZURES; STROKE;

EID: 84893807492     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2013.10.004     Document Type: Review

References (92)

1. Annegers J.F., Hauser W.A., Lee J.R., et al. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995, 36(4):327-333.
2. Jensen F.E. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 2006, 18(6):628-633.
3. Glass H.C., Pham T.N., Danielsen B., et al. Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998-2002. J Pediatr 2009, 154(1):24-28.e1.
4. Lanska M.J., Lanska D.J., Baumann R.J., et al. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology 1995, 45(4):724-732.
5. Saliba R.M., Annegers J.F., Waller D.K., et al. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol 1999, 150(7):763-769.
6. Malone A., Ryan C.A., Fitzgerald A., et al. Interobserver agreement in neonatal seizure identification. Epilepsia 2009, 50(9):2097-2101.
7. Murray D.M., Boylan G.B., Ali I., et al. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008, 93(3):F187-F191.
8. Volpe J.J. Neonatal seizures. Neurology of the newborn 2008, 203-244. WB Saunders, Philadelphia. J.J. Volpe (Ed.).
9. Rahman S., Footitt E.J., Varadkar S., et al. Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 2013, 55(1):23-36.
10. Uria-Avellanal C., Marlow N., Rennie J.M. Outcome following neonatal seizures. Semin Fetal Neonatal Med 2013, 18(4):224-232.
11. Holmes G.L. The long-term effects of neonatal seizures. Clin Perinatol 2009, 36(4):901-914. vii-viii.
12. Jensen F.E. Neonatal seizures: an update on mechanisms and management. Clin Perinatol 2009, 36(4):881-900. vii.
13. Dulac O., Milh M., Holmes G.L. Brain maturation and epilepsy. Handb Clin Neurol 2013, 111:441-446.
14. Huttenlocher P.R., de Courten C., Garey L.J., et al. Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci Lett 1982, 33(3):247-252.
15. Takashima S., Chan F., Becker L.E., et al. Morphology of the developing visual cortex of the human infant: a quantitative and qualitative Golgi study. J Neuropathol Exp Neurol 1980, 39(4):487-501.
16. Rakhade S.N., Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009, 5(7):380-391.
17. Sanchez R.M., Jensen F.E. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 2001, 42(5):577-585.
18. Dzhala V.I., Staley K.J. Excitatory actions of endogenously released GABA contribute to initiation of ictal epileptiform activity in the developing hippocampus. J Neurosci 2003, 23(5):1840-1846.
19. Dzhala V.I., Talos D.M., Sdrulla D.A., et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005, 11(11):1205-1213.
20. Khazipov R., Khalilov I., Tyzio R., et al. Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus. Eur J Neurosci 2004, 19(3):590-600.
21. Jiang M., Lee C.L., Smith K.L., et al. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J Neurosci 1998, 18(20):8356-8368.
22. McCabe B.K., Silveira D.C., Cilio M.R., et al. Reduced neurogenesis after neonatal seizures. J Neurosci 2001, 21(6):2094-2103.
23. Montgomery E.M., Bardgett M.E., Lall B., et al. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Res Dev Brain Res 1999, 112(1):107-116.
24. Lynch M., Sayin U., Bownds J., et al. Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur J Neurosci 2000, 12(7):2252-2264.
25. Miller S.P., Weiss J., Barnwell A., et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002, 58(4):542-548.
26. Glass H.C., Glidden D., Jeremy R.J., et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009, 155(3):318-323.
27. Glass H.C., Nash K.B., Bonifacio S.L., et al. Seizures and magnetic resonance imaging-detected brain injury in newborns cooled for hypoxic-ischemic encephalopathy. J Pediatr 2011, 159(5):731-735.e1.
28. Glass H.C., Bonifacio S.L., Sullivan J., et al. Magnetic resonance imaging and ultrasound injury in preterm infants with seizures. J Child Neurol 2009, 24(9):1105-1111.
29. Wusthoff C.J., Dlugos D.J., Gutierrez-Colina A., et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. J Child Neurol 2011, 26(6):724-728.
30. Clancy R.R., Legido A., Lewis D. Occult neonatal seizures. Epilepsia 1988, 29(3):256-261.
31. Bye A., Flanagan D. Electroencephalograms, clinical observations and the monitoring of neonatal seizures. J Paediatr Child Health 1995, 31(6):503-507.
32. Shellhaas R.A., Chang T., Tsuchida T., et al. The American Clinical Neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol 2011, 28(6):611-617.
33. Clancy R.R. The contribution of EEG to the understanding of neonatal seizures. Epilepsia 1996, 37(Suppl 1):S52-S59.
34. Wusthoff C.J. Diagnosing neonatal seizures and status epilepticus. J Clin Neurophysiol 2013, 30(2):115-121.
35. McCoy B., Hahn C.D. Continuous EEG monitoring in the neonatal intensive care unit. J Clin Neurophysiol 2013, 30(2):106-114.
36. Glass H.C., Wusthoff C.J., Shellhaas R.A. Amplitude-integrated electro-encephalography: the child neurologist's perspective. J Child Neurol 2013, 28(10):1342-1350.
37. Mastrangelo M., Fiocchi I., Fontana P., et al. Acute neonatal encephalopathy and seizures recurrence: a combined aEEG/EEG study. Seizure 2013, 22(9):703-707.
38. Hellstrom-Westas L. Comparison between tape-recorded and amplitude-integrated EEG monitoring in sick newborn infants. Acta Paediatr 1992, 81(10):812-819.
39. Toet M.C., van der Mei W., de Vries L.S., et al. Comparison between simultaneously recorded amplitude integrated electroencephalogram (cerebral function monitor) and standard electroencephalogram in neonates. Pediatrics 2002, 109(5):772-779.
40. Shah D.K., Mackay M.T., Lavery S., et al. Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. Pediatrics 2008, 121(6):1146-1154.
41. Rennie J.M., Chorley G., Boylan G.B., et al. Non-expert use of the cerebral function monitor for neonatal seizure detection. Arch Dis Child Fetal Neonatal Ed 2004, 89(1):F37-F40.
42. Boylan G.B., Stevenson N.J., Vanhatalo S. Monitoring neonatal seizures. Semin Fetal Neonatal Med 2013, 18(4):202-208.
43. Temko A., Thomas E., Marnane W., et al. Performance assessment for EEG-based neonatal seizure detectors. Clin Neurophysiol 2011, 122(3):474-482.
44. Temko A., Lightbody G., Boylan G., et al. Online EEG channel weighting for detection of seizures in the neonate. Conf Proc IEEE Eng Med Biol Soc 2011, 2011:1447-1450.
45. Temko A., Boylan G., Marnane W., et al. Robust neonatal EEG seizure detection through adaptive background modeling. Int J Neural Syst 2013, 23(4):1350018.
46. Temko A., Stevenson N., Marnane W., et al. Inclusion of temporal priors for automated neonatal EEG classification. J Neural Eng 2012, 9(4):046002.
47. Bonifacio S.L., Miller S.P. Neonatal seizures and brain imaging. J Pediatr Neurol 2009, 7(1):61-67.
48. Booth D., Evans D.J. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 2004, (4). CD004218.
49. Slaughter L.A., Patel A.D., Slaughter J.L. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol 2013, 28(3):351-364.
50. Bittigau P., Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002, 99(23):15089-15094.
51. Painter M.J., Scher M.S., Stein A.D., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999, 341(7):485-489.
52. Lynch N.E., Stevenson N.J., Livingstone V., et al. The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy. Epilepsia 2012, 53(3):549-557.
53. Grimshaw J.M., Russell I.T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993, 342(8883):1317-1322.
54. Guillet R., Kwon J.M. Prophylactic phenobarbital administration after resolution of neonatal seizures: survey of current practice. Pediatrics 2008, 122(4):731-735.
55. Hellstrom-Westas L., Blennow G., Lindroth M., et al. Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period. Arch Dis Child Fetal Neonatal Ed 1995, 72(2):F97-F101.
56. Guillet R., Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol 2007, 22(4):389-395.
57. Bartha A.I., Shen J., Katz K.H., et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 2007, 37(2):85-90.
58. Wheless J.W., Clarke D.F., Arzimanoglou A., et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007, 9(4):353-412.
59. Bassan H., Bental Y., Shany E., et al. Neonatal seizures: dilemmas in workup and management. Pediatr Neurol 2008, 38(6):415-421.
60. Boylan G.B., Rennie J.M., Chorley G., et al. Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology 2004, 62(3):486-488.
61. Glass H.C., Kan J., Bonifacio S.L., et al. Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol 2012, 46(2):111-115.
62. Silverstein F.S., Ferriero D.M. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008, 39(2):77-79.
63. Mbizvo G.K., Dixon P., Hutton J.L., et al. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database Syst Rev 2012, (9). CD001901.
64. Kim J.S., Kondratyev A., Tomita Y., et al. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007, 48(Suppl 5):19-26.
65. Manthey D., Asimiadou S., Stefovska V., et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005, 193(2):497-503.
66. Talos D.M., Chang M., Kosaras B., et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res 2013, 73(1):24-30.
67. Kilicdag H., Daglioglu K., Erdogan S., et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 2013, 89(5):355-360.
68. Tulloch J.K., Carr R.R., Ensom M.H. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther 2012, 17(1):31-44.
69. Merhar S.L., Schibler K.R., Sherwin C.M., et al. Pharmacokinetics of levetiracetam in neonates with seizures. J Pediatr 2011, 159(1):152-154.e3.
70. Sharpe C.M., Capparelli E.V., Mower A., et al. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res 2012, 72(1):43-49.
71. Abend N.S., Gutierrez-Colina A.M., Monk H.M., et al. Levetiracetam for treatment of neonatal seizures. J Child Neurol 2011, 26(4):465-470.
72. Khan O., Chang E., Cipriani C., et al. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 2011, 44(4):265-269.
73. Furwentsches A., Bussmann C., Ramantani G., et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure 2010, 19(3):185-189.
74. Sheth R.D., Buckley D.J., Gutierrez A.R., et al. Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol 1996, 19(2):165-170.
75. Hu K.C., Chiu N.C., Ho C.S., et al. Continuous midazolam infusion in the treatment of uncontrollable neonatal seizures. Acta Paediatr Taiwan 2003, 44(5):279-281.
76. Castro Conde J.R., Hernandez Borges A.A., Domenech Martinez E., et al. Midazolam in neonatal seizures with no response to phenobarbital. Neurology 2005, 64(5):876-879.
77. Sirsi D., Nangia S., LaMothe J., et al. Successful management of refractory neonatal seizures with midazolam. J Child Neurol 2008, 23(6):706-709.
78. Lundqvist M., Agren J., Hellstrom-Westas L., et al. Efficacy and safety of lidocaine for treatment of neonatal seizures. Acta Paediatr 2013, 102(9):863-867.
79. van den Broek M.P., Rademaker C.M., Straaten H.L., et al. Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing. Arch Dis Child Fetal Neonatal Ed 2013, 98(4):F341-F345.
80. van den Broek M.P., Huitema A.D., van Hasselt J.G., et al. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures. Clin Pharmacokinet 2011, 50(7):461-469.
81. Malingre M.M., Van Rooij L.G., Rademaker C.M., et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr 2006, 165(9):598-604.
82. Cha B.H., Silveira D.C., Liu X., et al. Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res 2002, 51(3):217-232.
83. Liu Y., Barks J.D., Xu G., et al. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004, 35(6):1460-1465.
84. Clark A.M., Kriel R.L., Leppik I.E., et al. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers. Epilepsia 2013, 54(6):1099-1105.
85. Clark A.M., Kriel R.L., Leppik I.E., et al. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate. Epilepsia 2013, 54(6):1106-1111.
86. Khanna A., Walcott B.P., Kahle K.T. Limitations of current GABA agonists in neonatal seizures: toward GABA modulation via the targeting of neuronal Cl(-) transport. Front Neurol 2013, 4:78.
87. Dzhala V.I., Brumback A.C., Staley K.J. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 2008, 63(2):222-235.
88. Cleary R.T., Sun H., Huynh T., et al. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS One 2013, 8(3):e57148.
89. Liu Y., Shangguan Y., Barks J.D., et al. Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia-ischemia model. Pediatr Res 2012, 71(5):559-565.
90. Kahle K.T., Barnett S.M., Sassower K.C., et al. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol 2009, 24(5):572-576.
91. Chabwine J.N., Vanden Eijnden S. A claim for caution in the use of promising bumetanide to treat neonatal seizures. J Child Neurol 2011, 26(5):657-658. [author reply: 658-9].
92. ClinicalTrials.gov. Identifier: NCT01720667.